The PD-L1 expression was positive in 110/547 (20.1%) of the cases in tumour proportion score (TPS) cut-off ≥ 25% and in 144/547 (26.3%) when evaluated in combined positive score (CPS) ≥ 1 (Fig. 1). The gene discussed is CD274; the disease is neoplasm.